Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 1.990
-0.010 (-0.50%)
Jan 22, 2026, 4:06 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 9.87 million as of January 22, 2026. Its market cap has increased by 50.54% in one year.
Market Cap
9.87M
Enterprise Value
9.59M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1.99
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 9.87M, a decrease of -70.66%. That is a compound annual growth rate of -26.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 9.62M | 5.41% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 27.61M |
| Aptamer Group | 25.62M |
| Fusion Antibodies | 15.06M |
| Oxford BioDynamics | 12.06M |
| IXICO | 10.66M |
| Futura Medical | 7.05M |
| OptiBiotix Health | 6.61M |
| Nuformix | 6.33M |